信息来源:ACR官网 https://rheumatology.org/ https://rheumatology.org/meetings/acr-convergence 医脉通是专业的在线医生平台,“感知世界医学脉搏,助力中国临床决策”是平台的使命。医脉通旗下拥有「临床指南」「用药参考」「医学文献王」「医知源」「e研...
2024 年美国风湿病学会年会(ACR Convergence 2024)已于美国华盛顿圆满落幕,会上重磅发布的一系列风湿病学领域新型药物及疗法的最新研究进展、疾病治疗经验等积极推进着学科的发展。为加强我国风湿病学领域与国际的交流与合作,帮助广大风湿...
2024 年美国风湿病学会年会(ACR Convergence 2024)已于美国华盛顿圆满落幕,会上重磅发布的一系列风湿病学领域新型药物及疗法的最新研究进展、疾病治疗经验等积极推进着学科的发展。为加强我国风湿病学领域与国际的交流与合作,帮助广大风湿科同道获悉 ACR 年会最新信息,Wiley 作为 ACR 在中国的授权合作方,由礼来提供学术...
2024 年美国风湿病学会年会(ACR Convergence 2024)已于美国华盛顿圆满落幕,会上重磅发布的一系列风湿病学领域新型药物及疗法的最新研究进展、疾病治疗经验等积极推进着学科的发展。为加强我国风湿病学领域与国际的交流与合作,帮助广大风湿科同道获悉 ACR 年会最新信息,Wiley 作为 ACR 在中国的授权合作方,由礼来提供学术...
ACR Convergence 2024- American College of Rheumatology Annual Meeting 时间/Date: 14-19 November, 2024 地点/Venue: Walter E. Washington Convention Center Washington, DC, United States ACR Convergence, the ACR's annual meeting, is the premier educational event for physicians, health professionals, and...
ACR Convergence 2025- American College of Rheumatology Annual Meeting 时间/Date: October 24–29, 2025 地点/Venue: Chicago, Illinois, United States ACR Convergence, the ACR's annual meeting, is the premier educational event for physicians, health professionals, and scientists who treat or research ...
biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced acceptance of an oral presentation at the upcomingAmerican College of Rheumatology (ACR) Convergence2024 meeting, taking placeNovember 14-19, 2024, inWashington, D....
American College of Rheumatology Designed for iPad Free Screenshots iPad iPhone Description ACR Convergence 2024 takes place November 14-19 in Washington, D.C. Download the app to access details about sessions, speakers, exhibitors, and posters. Personalize your schedule, take notes, find directions ...
disease, and GS-6791/NX-0479, an IRAK4 degrader discovered in collaboration with Gilead Sciences and also in IND-enabling studies, in two posters at ACR Convergence 2024, the annual meeting of the American College of Rheu...
a first-in-class treatment for osteoarthritis, today announces it will be presenting the results from its Phase II trial of LEVI-04 in an oral presentation at the American College of Rheumatology's annual meeting, ACR Convergence 2024, being held from 14 November to 19 Nov...